The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Stereochemistry in Drug Action
Open accessAbstract
The importance of stereochemistry in drug action is gaining greater attention in medical practice, and a basic knowledge of the subject will be necessary for clinicians to make informed decisions regarding the use of single-enantiomer drugs. Many of the drugs currently used in psychiatric practice are mixtures of enantiomers. For some therapeutics, single-enantiomer formulations can provide greater selectivities for their biological targets, improved therapeutic indices, and/or better pharmacokinetics than a mixture of enantiomers. This article reviews the nomenclature for describing stereochemistry and enantiomers, emphasizes the potential biological and pharmacologic differences between the 2 enantiomers of a drug, and highlights the clinical experience with single enantiomers of the selective serotonin reuptake inhibitors fluoxetine and citalopram. In some cases, both a mixture of enantiomers and a single-enantiomer formulation of a drug will be available simultaneously. In these cases, familiarity with stereochemistry and its pharmacologic implications will aid the practicing physician to provide optimal pharmacotherapy to his or her patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Owens, M. J., Knight, D. L., & Nemeroff, C. B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01145-3 · Cited by 516
Self-citationFixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients
Burke, W. J., Gergel, I., & Bose, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0410 · Cited by 350
Wade, A., Michael Lemming, O., & Bang Hedegaard, K. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00001 · Cited by 231
Montgomery, S. A., Loft, H., Sanchez, C., Reines, E. H., & Papp, M. (2001) · Pharmacology and Toxicology · doi:10.1034/j.1600-0773.2001.d01-118.x · Cited by 174
Gorman, J. M., Korotzer, A., & Su, G. (2002) · CNS Spectrums · doi:10.1017/s1092852900028595 · Cited by 169
Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.
Stevens, J. C., & Wrighton, S. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38409-0 · Cited by 138
Escitalopram: A Second-Generation SSRI
Owens, M. J., & Rosenbaum, J. F. (2002) · CNS Spectrums · doi:10.1017/s1092852900028583 · Cited by 40
Self-citationThe Development of Single-Isomer Molecules: Why and How
Hutt, A. J. (2002) · CNS Spectrums · doi:10.1017/s1092852900028558 · Cited by 31
Flockhart, D. A., & Nelson, H. S. (2002) · CNS Spectrums · doi:10.1017/s109285290002856x · Cited by 5
Cited by
Laboratory of Toxicology, F. O. P., Chuong, P.-H., Nguyen, L. A., Department of Pharmacy, L. S. P. C. H., He, H., & Department of Analytical Chemistry, C. P. U. (2006) · International Journal of Biomedical Science · doi:10.59566/ijbs.2006.2085 · Cited by 1,224
Advances in Catalytic Asymmetric Dearomatization
Zheng, C., & You, S.-L. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01651 · Cited by 427
Stanley, J. K., Ramirez, A. J., Chambliss, C. K., & Brooks, B. W. (2007) · Chemosphere · doi:10.1016/j.chemosphere.2007.04.080 · Cited by 255
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Applications and potential of in silico approaches for psychedelic chemistry
Karabulut, S., Kaur, H., & Gauld, J. W. (2023) · Molecules · doi:10.3390/molecules28165966 · Cited by 8
Metadata
- Authors
- McConathy, J., & Owens, M. J.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-04-01
- Volume
- 5
- Issue
- 2
- Pages
- 70-73
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- OpenAlex
- W1983317947
- Cited by
- 294
- References
- 9
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stereochemistry in Drug Action. https://app.cochat.ai/papers/10.4088/pcc.v05n0202
- The paper
- McConathy, J., & Owens, M. J. (2003). Stereochemistry in Drug Action. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v05n0202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.